Insider Transactions in Q1 2023 at Kempharm, Inc (KMPH)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2023
|
Tamara A Seymour Director |
BUY
Open market or private purchase
|
Direct |
519
+41.92%
|
$2,076
$4.82 P/Share
|
|
Mar 14
2023
|
Joshua Schafer CCO & EVP, Bus. Development |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$8,000
$4.61 P/Share
|
|
Mar 10
2023
|
R. La Duane Clifton CFO & Treasurer |
BUY
Open market or private purchase
|
Direct |
1,725
+13.55%
|
$6,900
$4.15 P/Share
|
|
Mar 10
2023
|
Timothy J. Sangiovanni SVP, Corporate Controller |
BUY
Open market or private purchase
|
Direct |
1,200
+11.19%
|
$4,800
$4.14 P/Share
|
|
Mar 09
2023
|
David S Tierney Director |
BUY
Open market or private purchase
|
Direct |
5,000
+31.58%
|
$20,000
$4.15 P/Share
|
|
Mar 09
2023
|
Matthew R Plooster Director |
BUY
Open market or private purchase
|
Direct |
11,000
+37.29%
|
$44,000
$4.2 P/Share
|
|
Mar 09
2023
|
Richard W Pascoe Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+25.02%
|
$40,000
$4.2 P/Share
|
|
Jan 13
2023
|
Richard W Pascoe Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
9,500
+32.23%
|
$47,500
$5.44 P/Share
|
|
Jan 13
2023
|
R. La Duane Clifton CFO & Treasurer |
BUY
Open market or private purchase
|
Direct |
635
+3.23%
|
$3,175
$5.7 P/Share
|